Tecartus (brexucabtagene autoleucel) for the Treatment of Mantle Cell Lymphoma (MCL)
MCL is a rare type of Non-Hodgkin’s cancerous B-cell lymphoma. Credit: Kite, a Gilead Company.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more